Systemic vasoplegia is common in patients undergoing liver transplantation. In this report, we present a case in which treatment with conventional vasopressors caused peripheral arterial spasm, rendering arterial blood pressure monitoring impossible. Administration of methylene blue resolved the vasospasm; however, concern for toxic dose requirements limited its use. Hydroxocobalamin administration resolved the vasospasm and increased blood pressure without the potential adverse effects seen with methylene blue. This case represents the first report of hydroxocobalamin use in liver transplantation and may represent a new option for the treatment of vasoplegia and the potential vasospasm that may result from traditional vasopressors.

Download full-text PDF

Source
http://dx.doi.org/10.1213/XAA.0000000000000398DOI Listing

Publication Analysis

Top Keywords

liver transplantation
12
blood pressure
12
methylene blue
8
resolved vasospasm
8
hydroxocobalamin vasoplegic
4
vasoplegic syndrome
4
syndrome liver
4
transplantation restoration
4
restoration blood
4
vasospasm
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!